Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Hereditary Non-Polyposis Colorectal Cancer: the rise and fall of a confusing term.

Jass JR.

World J Gastroenterol. 2006 Aug 21;12(31):4943-50. Review.

2.

Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.

Carethers JM, Stoffel EM.

World J Gastroenterol. 2015 Aug 21;21(31):9253-61. doi: 10.3748/wjg.v21.i31.9253. Review.

3.

Identification and classification of hereditary nonpolyposis colorectal cancer (Lynch syndrome): adapting old concepts to recent advancements. Report from the Italian Association for the study of Hereditary Colorectal Tumors Consensus Group.

Ponz de Leon M, Bertario L, Genuardi M, Lanza G, Oliani C, Ranzani GN, Rossi GB, Varesco L, Venesio T, Viel A.

Dis Colon Rectum. 2007 Dec;50(12):2126-34. Epub 2007 Sep 27. Review.

PMID:
17899274
4.

Lynch syndrome and related familial colorectal cancers.

Abdel-Rahman WM, Peltomäki P.

Crit Rev Oncog. 2008;14(1):1-22; discussion 23-31. Review.

PMID:
19105568
5.

Identification of HNPCC by molecular analysis of colorectal and endometrial tumors.

Vasen HF, Hendriks Y, de Jong AE, van Puijenbroek M, Tops C, Bröcker-Vriends AH, Wijnen JT, Morreau H.

Dis Markers. 2004;20(4-5):207-13. Review.

6.

[Identification and management of HNPCC syndrome (hereditary non polyposis colon cancer), hereditary predisposition to colorectal and endometrial adenocarcinomas].

Olschwang S, Bonaïti C, Feingold J, Frébourg T, Grandjouan S, Lasset C, Laurent-Puig P, Lecuru F, Millat B, Sobol H, Thomas G, Eisinger F.

Bull Cancer. 2004 Apr;91(4):303-15. Review. French.

7.

Review article: The Lynch syndrome (hereditary nonpolyposis colorectal cancer).

Vasen HF.

Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:113-26. doi: 10.1111/j.1365-2036.2007.03479.x. Review.

8.

Suspected hereditary nonpolyposis colorectal cancer: International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) criteria and results of genetic diagnosis.

Park JG, Vasen HF, Park KJ, Peltomaki P, Ponz de Leon M, Rodriguez-Bigas MA, Lubinski J, Beck NE, Bisgaard ML, Miyaki M, Wijnen JT, Baba S, Lynch HT.

Dis Colon Rectum. 1999 Jun;42(6):710-5; discussion 715-6.

PMID:
10378593
9.

Hereditary non-polyposis colorectal cancer/Lynch syndrome in three dimensions.

Kravochuck SE, Church JM.

ANZ J Surg. 2016 Mar 16. doi: 10.1111/ans.13483. [Epub ahead of print]

PMID:
26990828
10.

Review article: Detection and management of hereditary non-polyposis colorectal cancer (Lynch syndrome).

Ramsoekh D, Van Leerdam ME, Wagner A, Kuipers EJ.

Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:101-11. doi: 10.1111/j.1365-2036.2007.03492.x. Review.

11.

Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.

Johnson V, Lipton LR, Cummings C, Eftekhar Sadat AT, Izatt L, Hodgson SV, Talbot IC, Thomas HJ, Silver AJ, Tomlinson IP.

J Med Genet. 2005 Oct;42(10):756-62. Epub 2005 Mar 23.

12.

Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis.

Jasperson KW, Vu TM, Schwab AL, Neklason DW, Rodriguez-Bigas MA, Burt RW, Weitzel JN.

Fam Cancer. 2010 Jun;9(2):99-107. doi: 10.1007/s10689-009-9290-4. Erratum in: Fam Cancer. 2013 Sep;12(3):583.

13.

Familial colorectal cancer type X: the other half of hereditary nonpolyposis colon cancer syndrome.

Lindor NM.

Surg Oncol Clin N Am. 2009 Oct;18(4):637-45. doi: 10.1016/j.soc.2009.07.003. Review.

14.

Microsatellite instability as a predictor of a mutation in a DNA mismatch repair gene in familial colorectal cancer.

Liu T, Wahlberg S, Burek E, Lindblom P, Rubio C, Lindblom A.

Genes Chromosomes Cancer. 2000 Jan;27(1):17-25.

PMID:
10564582
15.

Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic.

Lipton LR, Johnson V, Cummings C, Fisher S, Risby P, Eftekhar Sadat AT, Cranston T, Izatt L, Sasieni P, Hodgson SV, Thomas HJ, Tomlinson IP.

J Clin Oncol. 2004 Dec 15;22(24):4934-43. Erratum in: J Clin Oncol. 2005 May 20;23(15):3652.

PMID:
15611508
16.

A population-based study of hereditary non-polyposis colorectal cancer: evidence of pathologic and genetic heterogeneity.

Warden G, Harnett D, Green J, Wish T, Woods MO, Green R, Dicks E, Rahman P, Zhai G, Parfrey P.

Clin Genet. 2013 Dec;84(6):522-30. doi: 10.1111/cge.12080. Epub 2013 Feb 7.

PMID:
23278430
17.

Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status.

Valle L, Perea J, Carbonell P, Fernandez V, Dotor AM, Benitez J, Urioste M.

J Clin Oncol. 2007 Mar 1;25(7):781-6. Epub 2007 Jan 16.

PMID:
17228022
18.

Clinical implications of molecular diagnosis in hereditary nonpolyposis colorectal cancer.

Möslein G.

Recent Results Cancer Res. 2003;162:73-8. Review.

PMID:
12790322
19.
20.

Genetic susceptibility to non-polyposis colorectal cancer.

Lynch HT, de la Chapelle A.

J Med Genet. 1999 Nov;36(11):801-18. Review.

Supplemental Content

Support Center